(S (NP-SBJ (JJ Platelet-activating) (NN factor)) (VP (VBZ induces) (NP (NP-COOD (NP (JJ phospholipid) (NN turnover)) (, ,) (NP (NN calcium) (NN flux)) (, ,) (NP (JJ arachidonic) (NN acid) (NN liberation)) (, ,) (NP (NN eicosanoid) (NN generation)) (, ,) (CC and) (NP (JJ oncogene) (NN expression))) (PP (IN in) (NP (DT a) (JJ human) (NN B) (NN cell) (NN line))))) (. .))
(S (NP-SBJ (JJ Platelet-activating) (NN factor)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ potent) (NN mediator)) (PP (IN of) (NP (DT the) (JJ inflammatory) (NN response))))) (. .))
(S (NP-SBJ (NP (NNS Studies)) (PP (IN of) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (JJ platelet-activating) (NN factor)))))) (VP (VBP have) (VP (VBN centered) (PP (RB mainly) (IN around) (NP-COOD (NP (NNS neutrophils)) (, ,) (NP (NNS monocytes)) (, ,) (CC and) (NP (NNS platelets)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (NP-SBJ-74 (PRP we)) (VP (VBP begin) (S (NP-SBJ (-NONE- *-74)) (VP (TO to) (VP (VB uncover) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NN platelet-activating) (NN factor))) (PP (IN on) (NP (NN B) (NNS lymphocytes)))))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *-73)) (VP (VBG Employing) (NP (DT the) (JJ EBV-transformed) (JJ human) (NN B) (NN cell) (NN line) (NN SKW6.4)))) (, ,) (NP-SBJ-73 (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (JJ platelet-activating) (NN factor)) (ADVP (RB significantly)) (VP (VBZ alters) (NP (NP (NN membrane) (JJ phospholipid) (NN metabolism)) (VP (VBN indicated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN incorporation)) (PP (IN of) (NP (NN 32P))) (PP-COOD (PP (IN into) (NP-COOD (NP (NN phosphatidylcholine)) (, ,) (NP (NN phosphatidylinositol)) (, ,) (CC and) (NP (JJ phosphatidic) (NN acid)))) (CC but) (PP (ADVP (RB not) (RB significantly)) (IN into) (NP (NN phosphatidylethanolamine)))) (PP (IN at) (NP (NP (NNS concentrations)) (VP (VBG ranging) (PP (PP-COOD (PP (IN from) (NP (CD 10-LRB--9-RRB-) (NP (-NONE- *RNR*-75)))) (PP (TO to) (NP (CD 10-LRB--6-RRB-) (NP (-NONE- *RNR*-75))))) (NP-75 (NN M)))))))))))))) (. .))
(S (NP-SBJ (NP (NP (DT The) (JJ inactive) (NN precursor)) (, ,) (NP (JJ lyso-platelet-activating) (NN factor)) (, ,)) (PP (IN at) (NP (NP (DT a) (NN concentration)) (ADJP (ADJP (RB as) (JJ high)) (PP (IN as) (NP (CD 10-LRB--7-RRB-) (NN M))))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN membrane) (NNS phospholipids)))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S-COOD (S (NP-SBJ (NP (JJ platelet-activating) (NN factor)) (PP (IN from) (NP (QP (CD 10-LRB--12-RRB-) (TO to) (CD 10-LRB--6-RRB-)) (NN M)))) (VP (VBD induced) (NP (NP (ADJP-COOD (ADJP (JJ rapid)) (CC and) (ADJP (JJ significant))) (NN elevation)) (PP (IN in) (NP (JJ intracellular) (NN calcium) (NNS levels)))))) (, ,) (IN whereas) (S (NP-SBJ (JJ lyso-platelet-activating) (NN factor)) (VP (VBD was) (ADVP (RB again)) (ADJP-PRD (JJ ineffective))))))) (. .))
(S (NP-SBJ-107 (PRP We)) (ADVP (RB further)) (VP (VBP demonstrate) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NP (JJ platelet-activating) (NN factor)) (VP (VBG binding) (PP (TO to) (NP (NN B) (NNS cells))))))) (PP (IN by) (S (NP-SBJ (-NONE- *-107)) (VP (VBG measuring) (NP-COOD (NP (ADJP (NP (JJ platelet-activating) (NN factor)) (JJ induced)) (JJ arachidonic) (NN acid) (NN release)) (CC and) (NP (JJ 5-hydroxyeicosatetraenoic) (NN acid) (NN production))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ-76 (JJ platelet-activating) (NN factor)) (VP (VBD was) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-76)) (VP (VBG inducing) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (JJ nuclear) (NNS proto-oncogenes) (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))))))))))) (. .))
(S (ADVP (RB Finally)) (NP-SBJ-77 (PRP we)) (VP (VBD explored) (NP (NP (DT the) (JJ possible) (NN role)) (PP (IN of) (NP (JJ 5-hydroxyeicosatetraenoic) (NN acid))) (PP (IN as) (NP (NP (DT a) (NN regulator)) (PP (IN of) (NP (JJ arachidonic) (NN acid) (NN liberation)))))) (S (NP-SBJ (-NONE- *-77)) (VP (VBG demonstrating) (SBAR (IN that) (S (NP-SBJ-78 (JJ endogenous) (NN 5-lipoxygenase) (NN activity)) (VP (VBZ modulates) (NP (ADJP (NP (JJ platelet-activating) (NN factor)) (JJ induced)) (JJ arachidonic) (NN acid) (NN release)) (S (NP-SBJ (-NONE- *-78)) (ADVP (RB perhaps)) (VP (VBG acting) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN phospholipase) (NN A2))))))))))))) (. .))
(S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ-79 (JJ platelet-activating) (NN factor)) (VP (VBZ is) (VP (VBN shown) (ADVP (RB here)) (S (NP-SBJ (-NONE- *-79)) (VP (TO to) (VP (VB have) (NP (DT a) (ADJP-COOD (ADJP (JJ direct)) (CC and) (ADJP (JJ profound))) (NN effect)) (PP (IN on) (NP (DT a) (JJ pure) (NN B) (NN cell) (NN line)))))))) (. .))
